Genel çocuk uzmanlarının çocukluk çağı astımı ve tedavisi konusundaki bilgi durumu ve uygulamaları

Amaç: Genel pediatri uzmanlarının çocukluk çağı astımı ve tedavisi konusunda yeterli bilgi düzeyi etkin kontrol için gereklidir. Bu çalışmanın amacı, pediatristlerin çocukluk çağı astımı ve tedavisi konusunda bilgi ve uygulamalarının değerlendirilmesidir.Gereç ve Yöntem: Çalışmaya astım tedavisi konusundaki yedi toplantıya katılan 52 pediatrist alındı. Toplantı öncesinde 23’ü astım, 19’u kendi uygulamaları hakkında toplam 42 soruluk anket uygulandı.Bulgular: Verilen yanıtlar arasında asistanlık yapılan hastane fark yaratmazken, muayenehane varlığı ve çalışma süresinin fark oluşturduğu belirlendi. “Sistemik steroidlerin akut astım alevlenmesinde rolü vardır” cümlesini, muayenehanesi olan pediatristlerden %82,4’ü, olmayanların %47,1’i doğru değerlendirdi (p= 0,014). Akut astım alevlenme sırası ve sonrasında pediatrik alerji merkezine sevk etme, muayenehanesi olanlarda anlamlı düşüktü (sırası ile p= 0,002 ve p= 0,016). Pediatrist olarak çalışma süresinin astımda inhale steroid kullanımı konusundaki bilgiyi etkilediği belirlendi (p= .005).Çıkarımlar: Sonuç olarak, uzmanlık süresi ve muayenehane varlığının, genel pediatristlerin astım ve tedavisi konusundaki bilgi ve uygulamalarını anlamlı olarak etkilediği saptanmıştır. Bu sonuçlarla astımlı çocuklara daha standardize ve etkin bakım sağlanabilmesi için mezuniyet sonrası eğitimin gerekliliği vurgulanmıştır.

Knowledge and practice of general pediatricians about childhood asthma and its treatment

Aim: It is essential educate general pediatricians about childhood asthma and its treatment to standardize care. The aim of this study wasto evaluate knowledge and practice of pediatricians about childhood asthma and its treatment.Material and Method: The study included 52 pediatricians who attended one of the seven meetings about asthma treatment. A questionnaire of 42 questions, 23 about asthma and its treatment and 19 about their practice were given before meeting.Results: Hospital of residency did not change answers to the questions, but presence of private office and duration of practice did. Among pediatricians who owned private office, 82.4% said the sentence: “systemic steroids have a role in acute asthma exacerbation treatment” was true, compared to the 47.1% of the ones without private office (p= 0.014). Referral to pediatric allergy center during or after acute asthmaexacerbation was significantly lower among the pediatricians who owned private Office (p= 0.002 and p= 0.016 respectively). Duration ofpractice as a pediatrician influenced knowledge about use of inhaled steroids in asthma (p= .005).Conclusions: In conclusion, duration of practice and presence of private office influence knowledge and practice of general pediatricians about asthma and its treatment. The essence of postgraduate education to provide children more standardized treatment was emphasized with these results.

___

  • 1. Prevention, Global Initiative for Asthma (GINA) 2007. Available from: http://www.ginasthma.org.
  • 2. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007; 120: 94-138.
  • 3. Sears MR. Epidemiology of childhood asthma. Lancet 1997; 350: 1015-20. 4. Blaiss MS, Hill B. Outcomes in pediatric asthma. Curr Allergy Asthma Rep 2005; 5: 431-6.
  • 5. Fuhlbrigge AL, Adams RJ, Guilbert TW, et al. The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med 2002; 166: 1044-9.
  • 6. Yuksel H, Sakar A, Dinç G, et al. The frequency of wheezing phenotypes and risk factors for persistence in aegean region of Turkey. J Asthma 2007; 44: 89-93.
  • 7. http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Asthma/Guidelines/asthma_final2008.pdf
  • 8. Urbano FL. Review of the NAEPP 2007 Expert Panel Report (EPR-3) on Asthma Diagnosis and Treatment Guidelines. J Manag Care Pharm 2008; 14: 41-9.
  • 9.http://www.thoracic.org/sections/publications/statements/pages/respiratory disease-pediatric/screening-for-asthma- in-children.html
  • 10. Lagerløv P, Veninga CC, Muskova M, et al. Asthma management in five European countries: doctors' knowledge, attitudes and prescribing behaviour. Drug Education Project (DEP) group. Eur Respir J 2000; 15: 25-9.
  • 11. Fong EW, Levin RH. Inhaled corticosteroids for asthma. Pediatr Rev 2007; 28: 30-5
  • 12. Gulliver T, Morton R, Eid N. Inhaled corticosteroids in children with asthma: pharmacologic determinants of safety and efficacy and other clinical considerations. Paediatr Drugs 2007; 9: 185-94.
  • 13. Lenney W, Wells NEJ, O’Neill BA. The burden of paediatric asthma. Eur Respir Rev 1994; 18: 49-62.
  • 14. Coates JR, Steven ID, Beilby J, Coffey G, Litt JC, Wagner C. Knowledge of and reported asthma management among South Australian general practitioners. Br J Gen Pract 1994; 44: 123-6.
  • 15. Wahlström R, Hummers-Pradier E, Lundborg CS, et al. Drug Education Project Group. Variations in asthma treatment in five European countries-judgement analysis of case simulations. Fam Pract 2002; 19: 452-60.
  • 16. Civelek E, Sekerel BE. Management of childhood asthma: physicians' perspective in Turkey. Pediatr Allergy Immunol 2004; 15: 372-5.